Clinical Trial Update: HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hepatic arterial infusion chemotherapy (HAIC) plus H101 versus HAIC alone for unresectable hepatocellular carcinoma at BCLC stages A-B. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• H101 (oncolytic adenovirus H101)
• HAIC (hepatic artery infusion chemotherapy)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN